StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Revvity, Inc.
NYSE:RVTY
Sector
Location
Market Cap
USD 11.61 B
Share Price
USD 98.47
Avg Daily Volume
1,289,863
Change (1 day)
-2.99%
Change (1 year)
-10.09%
Change (YTD)
-11.77%
Revvity, Inc. Accounts Payable for the year ending December 29, 2024: USD 167.46 M
Revvity, Inc. Accounts Payable is USD 167.46 M for the year ending December 29, 2024, a -17.96% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
-
Revvity, Inc. Accounts Payable for the year ending December 31, 2023 was USD 204.12 M, a -25.18% change year over year.
-
Revvity, Inc. Accounts Payable for the year ending December 31, 2022 was USD 272.83 M, a -16.00% change year over year.
-
Revvity, Inc. Accounts Payable for the year ending December 31, 2021 was USD 324.81 M, a -0.77% change year over year.
-
Revvity, Inc. Accounts Payable for the year ending December 31, 2020 was USD 327.32 M, a 38.78% change year over year.
Competitors
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%
Becton, Dickinson and Company
USD 177.09
BDX
+1.12
0.64%
Agilent Technologies, Inc.
USD 120.08
A
-3.20
-2.60%
GE HealthCare Technologies Inc.
USD 74.45
GEHC
-0.68
-0.91%
Natera, Inc.
USD 158.18
NTRA
-2.25
-1.40%
Laboratory Corporation of America Holdings
USD 249.80
LH
+0.18
0.07%
bioMérieux S.A.
USD 139.50
BIM.PA
+0.06
0.04%
Baxter International Inc.
USD 28.53
BAX
-0.17
-0.59%
Qiagen N.V.
USD 48.28
QGEN
+0.15
0.31%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.20
603392.SS
-0.10
-1.20%
Exact Sciences Corporation
USD 54.30
EXAS
+2.39
4.60%
Tempus AI, Inc.
USD 57.82
TEM
+0.94
1.65%
Globus Medical, Inc.
USD 57.37
GMED
+0.25
0.44%
ConvaTec Group Plc
USD 3.48
CTEC.L
-0.04
-1.11%
Bio-Rad Laboratories, Inc.
USD 250.81
BIO
-6.16
-2.40%
Hangzhou Tigermed Consulting Co., Ltd.
USD 5.94
3347.HK
-0.24
-3.88%
Key Data
| Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
|---|
Competitors
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
Thermo Fisher Scientific Inc.
USD 425.34
TMO
-9.52
-2.19%
Boston Scientific Corporation
USD 104.33
BSX
+1.13
1.09%
Siemens Healthineers AG
USD 53.64
SHL.DE
-0.22
-0.40%
Becton, Dickinson and Company
USD 177.09
BDX
+1.12
0.64%
Agilent Technologies, Inc.
USD 120.08
A
-3.20
-2.60%
GE HealthCare Technologies Inc.
USD 74.45
GEHC
-0.68
-0.91%
Natera, Inc.
USD 158.18
NTRA
-2.25
-1.40%
Laboratory Corporation of America Holdings
USD 249.80
LH
+0.18
0.07%
bioMérieux S.A.
USD 139.50
BIM.PA
+0.06
0.04%
Baxter International Inc.
USD 28.53
BAX
-0.17
-0.59%
Qiagen N.V.
USD 48.28
QGEN
+0.15
0.31%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.20
603392.SS
-0.10
-1.20%
Exact Sciences Corporation
USD 54.30
EXAS
+2.39
4.60%
Tempus AI, Inc.
USD 57.82
TEM
+0.94
1.65%
Globus Medical, Inc.
USD 57.37
GMED
+0.25
0.44%
ConvaTec Group Plc
USD 3.48
CTEC.L
-0.04
-1.11%
Bio-Rad Laboratories, Inc.
USD 250.81
BIO
-6.16
-2.40%
Hangzhou Tigermed Consulting Co., Ltd.
USD 5.94
3347.HK
-0.24
-3.88%